ascopubs.org

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study While overall survival ...
The New England Journal of Medicine

Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection

Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...

New method to track progression of Alzheimer's, related dementias based on metabolic, vascular brain changes

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a ...
Healio

Tissue perfusion pressure a potential target to guide clinical care of circulatory shock

Please provide your email address to receive an email when new articles are posted on . Tissue perfusion pressure may be a new target for BP optimization in circulatory shock. TPP was significantly ...